KARISBIO Trademark

Trademark Overview

On Wednesday, December 8, 2021, a trademark application was filed for KARISBIO with the United States Patent and Trademark Office. The USPTO has given the KARISBIO trademark a serial number of 97161684. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, January 26, 2024. This trademark is owned by Karis Bio Inc.. The KARISBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research; providing laboratory research services in the field of biological sciences; cell separation research services for scientific, research, clinical, medical, and biomanufacturing purposes; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research consulting in the field of genetics; conducting clinical trials for others in the field of cardiovascular disease; stem cell research services; scientific and technological research and development services in the field of biologics; development of cell therapy products; research on the subject of pharmaceuticals; scientific research for medical purposes in the field of cardiovascular disease
karisbio

General Information

Serial Number97161684
Word MarkKARISBIO
Filing DateWednesday, December 8, 2021
Status645 - FINAL REFUSAL - MAILED
Status DateFriday, January 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Pseudo MarkKARIS BIO
Goods and ServicesBiotechnology research; providing laboratory research services in the field of biological sciences; cell separation research services for scientific, research, clinical, medical, and biomanufacturing purposes; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research consulting in the field of genetics; conducting clinical trials for others in the field of cardiovascular disease; stem cell research services; scientific and technological research and development services in the field of biologics; development of cell therapy products; research on the subject of pharmaceuticals; scientific research for medical purposes in the field of cardiovascular disease

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 14, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKaris Bio Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 03722
KR
Party NameKaris Bio Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 03722
KR

Trademark Events

Event DateEvent Description
Friday, January 26, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, January 26, 2024FINAL REFUSAL E-MAILED
Friday, January 26, 2024FINAL REFUSAL WRITTEN
Saturday, December 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 29, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 25, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 25, 2023LETTER OF SUSPENSION E-MAILED
Friday, August 25, 2023SUSPENSION LETTER WRITTEN
Monday, July 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 21, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, April 21, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 27, 2023NON-FINAL ACTION E-MAILED
Friday, January 27, 2023NON-FINAL ACTION WRITTEN
Thursday, January 26, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, January 26, 2023WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
Saturday, January 21, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 9, 2022ASSIGNED TO LIE
Wednesday, October 19, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, September 16, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 16, 2022LETTER OF SUSPENSION E-MAILED
Friday, September 16, 2022SUSPENSION LETTER WRITTEN
Friday, September 16, 2022ASSIGNED TO EXAMINER
Tuesday, December 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 11, 2021NEW APPLICATION ENTERED

Related Keywords

karisbio research field services scientific clinical development cell medical providing cardiovascular